Skip to content

Effect of Auriculotherapy on Anxiety in adults within the Basic Health Unit

Effect of Auriculotherapy on Anxiety in adults in Primary Care: pilot clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-35n9nkj
Enrollment
Unknown
Registered
2022-09-22
Start date
2019-05-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

The State-Trait Anxiety Inventory (IDATE) research instrument will be applied and verified if the user meets the research inclusion criteria. Initially 25 participants were recruited. After applying t
E02.190.204

Sponsors

Universidade do Sul de Santa Catarina
Lead Sponsor
Unidade Básica de Saúde Central do Município de Palhoça
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 18 years old; both sexes; medium and high anxiety level

Exclusion criteria

Exclusion criteria: Users who are being treated with the following drugs: psychotropic drugs, antibiotics, corticosteroids and anabolics; pregnant women in the first trimester of pregnancy; illiterate.

Design outcomes

Primary

MeasureTime frame
Presentation of the expected outcome: Expected to evaluate the effects of auriculotherapy on anxiety and serum levels of the Brain Derived Neurotrophic Factor (BDNF), Neuron Specific Enolase (NSE) and S100 calcium binding protein B (S100B) biomarkers in adults in the scope of the Primary Health Care of a Basic Health Unit in the city of Palhoça/SC.

Secondary

MeasureTime frame
Expected find the Identification of the anxiety levels of the population served at the Basic Health Unit. ;is expected to do the description of the therapeutic effects of auriculotherapy in reducing the anxiety levels of the research participants.

Countries

Brazil

Contacts

Public ContactLetícia Siqueira

Universidade do Sul de Santa Catarina

leticiasiqueira@gmail.com+55-48-988121402

Outcome results

None listed

Source: REBEC (via WHO ICTRP)